Outset Medical (OM) Current Deferred Revenue (2019 - 2026)

Outset Medical (OM) has reported Current Deferred Revenue for 8 consecutive years, with $14.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue changed 0.24% year-over-year to $14.0 million in Q2 2026; TTM through Jun 2026 was $14.0 million, a 0.24% change from a year earlier, with the FY2025 full-year figure at $13.8 million, up 8.17% from the prior year.
• Current Deferred Revenue was $14.0 million for Q2 2026 at Outset Medical, up from $12.6 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $14.9 million in Q3 2025 and troughed at $6.8 million in Q1 2022.
• A 5-year average of $11.5 million and a median of $12.7 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue jumped 93.02% in 2022 and retreated 4.15% in 2026, its largest moves.
• Over 5 years, Current Deferred Revenue stood at $8.7 million in 2022, then surged by 35.38% to $11.7 million in 2023, then gained by 8.75% to $12.8 million in 2024, then rose by 8.17% to $13.8 million in 2025, then grew by 1.8% to $14.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $14.0 million (Q2 2026), $12.6 million (Q1 2026), and $13.8 million (Q4 2025), per Business Quant data.